T3S Technologies
Pre-clinicalT3S provides world-renown genetic expertise and ground-breaking technologies for difficult to express proteins.
About
T3S provides world-renown genetic expertise and ground-breaking technologies for difficult to express proteins.
Funding History
2Total raised: $1.9M
Seed$1.2MUndisclosedMay 15, 2021
Grant$750KNIH SBIROct 15, 2020
Company Info
TypePrivate
LocationUnited States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile